HUTCHMED (China) Limited
HCM
$12.20
$0.040.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.81% | -10.94% | -12.96% | -18.66% | -23.24% |
| Total Other Revenue | -- | -- | -- | -273.96% | -273.96% |
| Total Revenue | -8.81% | -10.94% | -12.96% | -7.28% | -1.41% |
| Cost of Revenue | -11.67% | -6.50% | -0.78% | -3.46% | -5.75% |
| Gross Profit | 106.11% | -113.75% | -111.74% | -221.12% | 61.59% |
| SG&A Expenses | 11.53% | 0.61% | -8.75% | -15.23% | -21.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.11% | -9.59% | -12.80% | -13.94% | -15.00% |
| Operating Income | -76.55% | -16.61% | 10.40% | 64.22% | 83.69% |
| Income Before Tax | -96.25% | -6.71% | 1,049.29% | 13,412.02% | 1,525.07% |
| Income Tax Expenses | -97.54% | -12.58% | 784.45% | 1,005.49% | 1,346.26% |
| Earnings from Continuing Operations | -96.06% | -5.85% | 1,099.19% | 23,008.94% | 1,207.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.94% | -21.45% | -86.62% | -643.07% | -383.68% |
| Net Income | -96.17% | -5.91% | 1,111.03% | 21,882.39% | 1,212.42% |
| EBIT | -76.55% | -16.61% | 10.40% | 64.22% | 83.69% |
| EBITDA | -173.86% | -19.33% | 17.57% | 76.44% | 93.20% |
| EPS Basic | -96.22% | -6.01% | 1,105.88% | 20,826.92% | 1,202.83% |
| Normalized Basic EPS | -71.43% | -47.16% | -17.13% | 466.67% | 294.78% |
| EPS Diluted | -96.49% | -5.47% | 1,200.50% | 11,039.58% | 1,168.55% |
| Normalized Diluted EPS | -70.78% | -46.72% | -16.95% | 510.00% | 287.18% |
| Average Basic Shares Outstanding | 0.79% | 0.57% | 0.34% | 0.27% | 0.19% |
| Average Diluted Shares Outstanding | 0.02% | 0.01% | 0.01% | 0.60% | 1.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |